Tellgen Corp

Tellgen Corp maintains a relatively strong liquidity position, with a current ratio of 4.91, indicating that it holds nearly five times more current assets than current liabilities. However, the company's free cash flow is negative at -36.0 million CNY, and capital expenditures are significant at -67.3 million CNY, suggesting ongoing investment in operations. The debt-to-equity ratio of 0.31 indicates a conservative capital structure, with long-term debt accounting for a small portion of total equity. Profitability metrics for Tellgen Corp are modest. The company's return on equity (ROE) is 0.25%, and return on assets (ROA) is 0.17%, both below the typical thresholds for strong performance in the medical equipment and supplies industry. Despite a gross profit of 244.5 million CNY, the company reported an operating loss of 2.8 million CNY, which may signal inefficiencies in cost management or pricing pressures. Tellgen Corp's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to localized market risks, such as regulatory changes or supply chain disruptions in its primary operating region. The company's growth trajectory appears mixed. While revenue for the latest period is reported at 363.8 million CNY, the operating loss and negative free cash flow suggest that growth is being funded through operational cash flow rather than profitability. The capital expenditure of 67.3 million CNY indicates a focus on expansion or modernization, but the net income of 3.6 million CNY is relatively low, which may limit the company's ability to sustain long-term growth without external financing. Risk factors for Tellgen Corp include liquidity concerns, as the company has negative net cash after subtracting total debt, and a low dilution risk, with no significant dilution potential identified in the current financial structure. The company's operating cash flow of 143.2 million CNY provides some buffer, but the negative free cash flow and capital expenditures suggest that the company is reinvesting heavily in its operations. Recent events and disclosures for Tellgen Corp include the latest financial filing, which shows a net income of 3.6 million CNY despite an operating loss. No recent earnings call transcripts or major regulatory filings are available in the current dataset, limiting the ability to assess management commentary or strategic direction.